Rosetta Genomics Stock Surges on Lung Cancer Dx Findings

A new study from Johns Hopkins and Rosetta researchers finds the miRview NSCLC test to be effective.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories